Prestige Consumer Healthcare
PBH
#3132
Rank
NZ$6.64 B
Marketcap
$134.56
Share price
0.35%
Change (1 day)
37.32%
Change (1 year)

P/E ratio for Prestige Consumer Healthcare (PBH)

P/E ratio as of November 2024 (TTM): -49.3

According to Prestige Consumer Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -49.3067. At the end of 2022 the company had a P/E ratio of 14.9.

P/E ratio history for Prestige Consumer Healthcare from 2005 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202214.9-7.6%
202116.153.12%
202010.5-115.61%
2019-67.5-368.86%
201825.1316.07%
20176.03-84.13%
201638.053.65%
201524.8-3.05%
201425.55.54%
201324.29.9%
201222.069.92%
201113.0-44.72%
201023.4-1188.1%
2009-2.15-114.29%
200815.130.97%
200711.5-43.43%
200620.3-117.9%
2005-114

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
10.4-121.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
14.4-129.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0219-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
11.0-122.39%๐Ÿ‡บ๐Ÿ‡ธ USA
70.4-242.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
28.5-157.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
26.5-153.73%๐Ÿ‡บ๐Ÿ‡ธ USA
8.34-116.91%๐Ÿ‡บ๐Ÿ‡ธ USA
236-578.52%๐Ÿ‡บ๐Ÿ‡ธ USA
39.2-179.56%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.